Cargando…
Clinical impact of microbiome in patients with decompensated cirrhosis
Cirrhosis is an increasing cause of morbidity and mortality. Recent studies are trying to clarify the role of microbiome in clinical exacerbation of patients with decompensated cirrhosis. Nowadays, it is accepted that patients with cirrhosis have altered salivary and enteric microbiome, characterize...
Autores principales: | Oikonomou, Theodora, Papatheodoridis, George V, Samarkos, Michael, Goulis, Ioannis, Cholongitas, Evangelos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141334/ https://www.ncbi.nlm.nih.gov/pubmed/30228776 http://dx.doi.org/10.3748/wjg.v24.i34.3813 |
Ejemplares similares
-
The significance of C-reactive protein to albumin ratio in patients with decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2020) -
Aspartate aminotransferase-to-platelet ratio index can predict the outcome in patients with stable decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2023) -
New prognostic score based on galectin-3 has similar performance to model for end-stage liver disease and sodium score in patients with stable decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2021) -
High serum ferritin is associated with worse outcome of patients with decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2017) -
The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis
por: Cholongitas, Evangelos, et al.
Publicado: (2015)